These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38529713)

  • 1. Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation of 5-HT2B GPCR activity: implications for drug discovery and development.
    Chauhan A; Singh J; Sangwan N; Avti PK
    J Recept Signal Transduct Res; 2024 Feb; 44(1):8-18. PubMed ID: 38529713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of conserved motifs and helices in 5HT
    Chauhan A; Sangwan N; Singh J; Prakash A; Medhi B; Avti PK
    J Biomol Struct Dyn; 2023; 41(22):13113-13126. PubMed ID: 36809314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Atomic Level Investigation of Sodium Ions Regulating Agonist and Antagonist Binding in the Active Site of a Novel Target 5HT
    Chauhan A; Singh J; Sangwan N; Dhawan R; Avti PK
    Cell Biochem Biophys; 2023 Jun; 81(2):253-267. PubMed ID: 37266904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Ion-Binding Sites for GPCR Pharmacology.
    Zarzycka B; Zaidi SA; Roth BL; Katritch V
    Pharmacol Rev; 2019 Oct; 71(4):571-595. PubMed ID: 31551350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT
    Denzinger K; Nguyen TN; Noonan T; Wolber G; Bermudez M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing the 5HT
    Chauhan A; Singh J; Sangwan N; Singh H; Prakash A; Medhi B; Avti PK
    Epilepsy Res; 2023 Aug; 194():107168. PubMed ID: 37302343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
    Margiotta E; Deganutti G; Moro S
    J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the transmembrane domain structures in GPCR Dock 2013 models.
    Wang T; Liu H; Duan Y
    J Struct Biol; 2018 Mar; 201(3):210-220. PubMed ID: 29174398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.
    Bhattacharya S; Subramanian G; Hall S; Lin J; Laoui A; Vaidehi N
    J Comput Aided Mol Des; 2010 Aug; 24(8):659-74. PubMed ID: 20512399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motions around conserved helical weak spots facilitate GPCR activation.
    Bibbe JM; Vriend G
    Proteins; 2021 Nov; 89(11):1577-1586. PubMed ID: 34272892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the putative G protein-coupled receptor (GPCR) docking site on GPCR kinase 2: insights from intact cell phosphorylation and recruitment assays.
    Beautrait A; Michalski KR; Lopez TS; Mannix KM; McDonald DJ; Cutter AR; Medina CB; Hebert AM; Francis CJ; Bouvier M; Tesmer JJ; Sterne-Marr R
    J Biol Chem; 2014 Sep; 289(36):25262-75. PubMed ID: 25049229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universality of the Sodium Ion Binding Mechanism in Class A G-Protein-Coupled Receptors.
    Selvam B; Shamsi Z; Shukla D
    Angew Chem Int Ed Engl; 2018 Mar; 57(12):3048-3053. PubMed ID: 29405531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1.
    Lückmann M; Trauelsen M; Bentsen MA; Nissen TAD; Martins J; Fallah Z; Nygaard MM; Papaleo E; Lindorff-Larsen K; Schwartz TW; Frimurer TM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7123-7128. PubMed ID: 30872479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
    Reinecke BA; Wang H; Zhang Y
    Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
    Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.